Provider Update – Redirection of Care & Holiday Closures

Redirection of Care

Blue Cross Blue Shield of Wyoming is introducing a new redirection of care program for certain medications. When clinically appropriate services will be authorized in the most cost-effective setting, such as an Infusion Center, providers office, or via Home Health. If needed, BCBSWY will assist members with finding an appropriate site for care.

Please note, redirection of care does not affect your patient’s prescription drug benefits.

If a member is affected by this program, it will be noted in the authorization letter. 

Who is Impacted:
As of January 1, 2022, the list below are the medications that will be subject to the redirection of care program for administration in the most cost-effective setting:

Neulasta Remicade
Avastin Rituxab
Herceptin Keytruda
Ocrevus Opdivo
Somatuline Soliris

This program will go into effect with new prescriptions or upon authorization renewal. Typically, medical authorizations expire one year from the date of the authorization.          

Questions:

We have a Redirection of Care Team. If you’re currently taking one of these medications and have questions or concerns, please call 307-823-6095.

Upcoming Holiday Closures

BCBSWY will be closed on Friday, December 24 and Friday, December 31 in observance of the Christmas and New Year holiday.

Share

Related Posts
Advanced Claim Editing, Document Processing, Authorization Pre-Check & More
Announcements We are excited to finally share our newly redesigned Provider Update. This update gives everyone a cleaner and more efficient design. Sign up…
Claims, Coding, URAC Guidelines & More
Advanced Claims Editing  We are sharing coding advice to help Providers prepare for our automated claims review process starting March of 2023. These ongoing tips…
Claims & Best Practices
Advanced Claims Editing  We are sharing coding advice to help Providers prepare for our automated claims review process starting March of 2023. These ongoing tips…

Fewer Hassles. Better Service.

Back to Top